tradingkey.logo

Bio Rad Laboratories Inc

BIO
301.500USD
+1.960+0.65%
종가 02/06, 16:00ET시세는 15분 지연됩니다
8.13B시가총액
손실P/E TTM

Bio Rad Laboratories Inc

301.500
+1.960+0.65%

자세한 내용은 Bio Rad Laboratories Inc 회사

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Inc 정보

종목 코드 BIO
회사 이름Bio Rad Laboratories Inc
상장일Mar 17, 1980
CEOSchwartz (Norman D)
직원 수7700
유형Ordinary Share
회계 연도 종료Mar 17
주소1000 Alfred Nobel Dr
도시HERCULES
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호94547
전화15107247000
웹사이트https://www.bio-rad.com/
종목 코드 BIO
상장일Mar 17, 1980
CEOSchwartz (Norman D)

Bio Rad Laboratories Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+951364.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+1071.00%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+709.00%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+739.00%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+308.00%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+493.00%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
+308.00%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
+308.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+951364.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+1071.00%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+709.00%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+739.00%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+308.00%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+493.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
270.00M
41.35%
EMEA
222.20M
34.03%
APAC
121.00M
18.53%
Other
39.80M
6.09%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Mon, Feb 2
마지막 업데이트: Mon, Feb 2
주주
주주 유형
주주
주주
비율
First Eagle Investment Management, L.L.C.
11.50%
Alice N. Schwartz Revocable Trust
8.13%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
기타
59.15%
주주
주주
비율
First Eagle Investment Management, L.L.C.
11.50%
Alice N. Schwartz Revocable Trust
8.13%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
기타
59.15%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
45.17%
Investment Advisor
40.02%
Individual Investor
8.25%
Corporation
8.13%
Hedge Fund
5.13%
Research Firm
1.16%
Pension Fund
1.12%
Bank and Trust
0.96%
Sovereign Wealth Fund
0.63%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
1040
20.58M
101.60%
-3.97K
2025Q3
1095
20.58M
103.17%
+603.60K
2025Q2
1114
19.81M
108.02%
-855.27K
2025Q1
1146
19.96M
99.31%
-2.83M
2024Q4
1140
19.39M
101.48%
-657.49K
2024Q3
1121
20.03M
101.42%
-386.71K
2024Q2
1139
20.32M
91.46%
+1.29M
2024Q1
1154
19.07M
91.02%
-2.25M
2023Q4
1187
19.09M
89.28%
-259.69K
2023Q3
1170
19.31M
88.28%
-552.69K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
First Eagle Investment Management, L.L.C.
2.52M
11.5%
+3.01K
+0.12%
Sep 30, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.13%
--
--
Sep 25, 2025
The Vanguard Group, Inc.
1.79M
8.17%
-53.01K
-2.88%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.48M
6.77%
-61.47K
-3.98%
Sep 30, 2025
Schwartz (Norman D)
1.39M
6.36%
+951.36K
+214.86%
Sep 25, 2025
Dimensional Fund Advisors, L.P.
1.06M
4.85%
+63.37K
+6.34%
Sep 30, 2025
Veritas Asset Management LLP
844.04K
3.85%
-19.10K
-2.21%
Sep 30, 2025
Ariel Investments, LLC
809.48K
3.7%
-9.14K
-1.12%
Sep 30, 2025
EARNEST Partners, LLC
609.28K
2.78%
+3.40K
+0.56%
Sep 30, 2025
State Street Investment Management (US)
571.60K
2.61%
-12.77K
-2.18%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Parnassus Value Select ETF
3.94%
First Trust Indxx Medical Devices ETF
2.15%
ROBO Global Healthcare Technology & Innovation ETF
1.61%
Schwab Ariel Opportunities ETF
1.6%
First Trust Health Care Alphadex Fund
1.49%
FPA Global Equity ETF
1.38%
First Eagle Global Equity ETF
1.21%
iShares Health Innovation Active ETF
1.17%
Pacer US Export Leaders ETF
1.03%
Harbor Health Care ETF
0.82%
더 보기
Parnassus Value Select ETF
비율3.94%
First Trust Indxx Medical Devices ETF
비율2.15%
ROBO Global Healthcare Technology & Innovation ETF
비율1.61%
Schwab Ariel Opportunities ETF
비율1.6%
First Trust Health Care Alphadex Fund
비율1.49%
FPA Global Equity ETF
비율1.38%
First Eagle Global Equity ETF
비율1.21%
iShares Health Innovation Active ETF
비율1.17%
Pacer US Export Leaders ETF
비율1.03%
Harbor Health Care ETF
비율0.82%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI